SGTI — Shengtai Pharmaceutical Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Shengtai Pharmaceutical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2012 June 30th | |
|---|---|
| Period Length: | 12 M |
| Source: | 10-K |
| Standards: | USG |
| Status: | Final |
| Net Income/Starting Line | 1.07 |
| Depreciation | |
| Amortisation | |
| Non-Cash Items | -0.834 |
| Other Non-Cash Items | |
| Changes in Working Capital | -32 |
| Change in Accounts Receivable | |
| Change in Inventories | |
| Change in Prepaid Expenses | |
| Change in Accounts Payable | |
| Change in Accrued Expenses | |
| Change in Taxes Payable | |
| Change in Other Liabilities | |
| Cash from Operating Activities | -23.7 |
| Capital Expenditures | -0.137 |
| Purchase of Fixed Assets | |
| Purchase / Acquisition of Intangibles | |
| Other Investing Cash Flow Items | -1.52 |
| Purchase of Investments | |
| Other Investing Cash Flow | |
| Cash from Investing Activities | -1.66 |
| Financing Cash Flow Items | -4.11 |
| Other Financing Cash Flow | |
| Net Issuance / Retirement of Debt | |
| Cash from Financing Activities | 26.1 |
| Foreign Exchange Effects | |
| Beginning Cash Balance | |
| Ending Cash Balance | |
| Net Change in Cash | 0.852 |